EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma
AUTOR(ES)
Lee, Jeong-Won
FONTE
Oxford University Press
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2736292Documentos Relacionados
- Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex
- Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2
- Expression of EphA2 and EphrinA‐1 in vulvar carcinomas and its relation to prognosis
- EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia
- Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors